Cargando…
Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies
Infection with the SARS-associated coronavirus (SARS-CoV) induces an atypical pulmonary disease with a high lethality rate. Although the initial SARS epidemic was contained, sporadic outbreaks of the disease still occur, suggesting a continuous need for a vaccine against this virus. We therefore exp...
Autores principales: | Kuate, Seraphin, Cinatl, Jindrich, Doerr, Hans Wilhelm, Überla, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103344/ https://www.ncbi.nlm.nih.gov/pubmed/17258782 http://dx.doi.org/10.1016/j.virol.2006.12.011 |
Ejemplares similares
-
Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus
por: Temchura, Vladimir V., et al.
Publicado: (2008) -
Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
por: Morgenstern, Birgit, et al.
Publicado: (2005) -
Investigation of the influence of EPs(®) 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses
por: Michaelis, Martin, et al.
Publicado: (2011) -
Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication
por: Chen, Chung-Jen, et al.
Publicado: (2008) -
Expression of RNA virus proteins by RNA polymerase II dependent expression plasmids is hindered at multiple steps
por: Ternette, Nicola, et al.
Publicado: (2007)